9th Annual Pharma IPR 2020

The Indian Pharma industry has generated astounding growth in the past decades fuelled by increasing burden of disease. In order for the Indian pharmaceutical industry to maximize its true potential, ideation, innovation and integration are pre-requisites to reaching this stupendous growth. The numerous innovations leading to discovery of new life-saving drugs are through intellectual property rights (IPRs). IPR is a requirement for pharma companies for identification, planning, commercialization and protection of invention. The intellectual property market has manifested growth at an unprecedented pace. Risks abound and rights holders need strategic knowledge to maximize their success in the jurisdiction. The Patent Act, 1970 has played a significant role in taking India to the global patent arena.

With this overarching global theme of Ideate and Innovate, CPhI Conferences is pleased to present the, '9th Annual Pharma IPR Conference' scheduled on 4 - 5 - 6 MARCH 2020 at Taj Santacruz, Mumbai.

Driven by powerful content and unmatched speaker profiles, the forum promises to provide an exceptional opportunity to bring all key stakeholders, IP Attorneys and Counsels from across the globe on a single platform to discuss, deliberate and share their thoughts on achieving the next phase of growth, recent trends and best practices in the Pharma IPR space!

Event Partners 2020

Gold Partners

Silver Partners

Past Event Partners

Gold Partners

Cocktail Partners

Silver Partners

Power Breakfast Partner

Bronze Partners

Technology Partner

Associate Partners

Lanyard Partner

Exhibit Partners


Key Topics


  • The New Era Blueprint of Global Pharma Intellectual Property Strategies
  • Global Perspective: The Patent Linkage for Pharmaceuticals
  • Brand and Generic Perspectives Latest FDA Initiatives in the Hatch-Waxman Space
  • Protection of Trade Secrets in a Globalized Environment
  • ANDA Filing and Litigation: Procedures to Respond
  • Five Years Later: Lessons Learned from the First Inter Partes Review
  • FDA Regulatory Law from Cradle to Grave
  • Generics to Complex Generics to Super Generics - The Reality and the Way Forward


  • Recent Evolution at EPO
  • Infringement of Second Medical Use in EU
  • Second Medical Use Patents - The Need to be Plausible
  • Supplementary Protection Certificate (SPC) Regime: A Regulation to Rule the Market for an Extended Time Period
  • World Leader in Biosimilars: Action Plan
  • Implications of IP Enforcement on Trademarks on Indian exports


  • Diversity in IP: Developing the Next Generation of Innovators and IP Leaders Patent Opposition vs. Patent Revocation in Court: Which is a Better Strategy to Adopt by Indian Pharma Industry National Pharmaceutical Pricing Authority (NPPA): The Price Control of the Life-Saving Drugs in India Fixed Dose Combination Products and its Regulatory challenges in approval in India and its future

Rest of the World

  • SOUTH AFRICA: Patent System and Litigation Strategies in South Africa
  • MIDDLE EAST: An Overview of the Patent Law to Gain Hassle-free Access in the Middle East
  • AUSTRALIA / NEW ZEALAND: Patents: Current Developments and Challenges in Australia and New Zealand
  • JAPAN: Country Focus: IP Revolution- Japanese National IP Strategies
  • CHINA: Paving the Way for Understanding the IP Policies in China
  • BRAZIL / MEXICO: Amendments in Patent Law and Recent Patent Infringement Case Laws

Benefits of Attending

Reinforce your position as an IP thought leader in the Indian Pharma Industry
Interact with Indian and International patent experts
Get effective solutions to the global pharma IPR related queries

Harness the learnings from recent cases to understand pharma patent litigation laws
Take advantage of focused networking sessions to enter into strategic partnerships
Strategise effective market entry into 10+ countries including US, Europe, UK, China, Japan, India, South Africa, Australia, Indonesia, Middle East, Brazil and Russia.

Media Partners

Copyright © 2019. All rights reserved. Informa Markets, a trading division of Informa PLC.